6 pending office actions • 5 art units • 6 examiners • 0 of 6 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 6 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 6 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 3 (50%) |
| §102 only | 1 (17%) |
| No statute on record | 2 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| JONES, JAMES | 1 | 88.5% | +4.3% |
| VAJDA, KRISTIN ANN | 1 | 84.1% | +10.6% |
| RZECZYCKI, PHILLIP MATTHEW | 1 | 57.4% | +45.0% |
| BELL, SARA ELIZABETH | 1 | 73.5% | +39.9% |
| EISEMAN, LYNSEY C | 1 | 49.0% | +39.4% |
| ALLEN, ROBERT F | 1 | 74.2% | +60.3% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18561634 | OPHTHALMIC PREPARATION FOR MYOPIA SUPPRESSION | VAJDA, KRISTIN ANN | 9d |
| 18564751 | Eyewear and Cartridge | JONES, JAMES | 60d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18026232 | DEVICE AND METHOD FOR INHIBITING CHOROIDAL THINNING | EISEMAN, LYNSEY C | 42d overdue |
| 16982152 | NON-INVASIVE CORNEA AND SCLERA STRENGTHENING DEVICE AND METHOD | ALLEN, ROBERT F | 35d overdue |
| 18266102 | Eyedrops for Inhibiting Myopia Progression in Children and Screening Method for Inhibitor of Myopia Progression in Children | BELL, SARA ELIZABETH | 30d overdue |
| 18561634 | OPHTHALMIC PREPARATION FOR MYOPIA SUPPRESSION | VAJDA, KRISTIN ANN | 9d |
| 18266103 | Eyedrops for Treating Scleral Thinning and Screening Method for Therapeutic Agent of Scleral Thinning | RZECZYCKI, PHILLIP MATTHEW | 9d |
| Art Unit | Apps |
|---|---|
| 1625 | 2 |
| 2872 | 1 |
| 1622 | 1 |
| 3796 | 1 |
| 3783 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18564751 | Eyewear and Cartridge | JONES, JAMES | 2872 | §102 | Non-Final OA | 60d | Pending | Nov 28, 2023 |
| 18561634 | OPHTHALMIC PREPARATION FOR MYOPIA SUPPRESSION | VAJDA, KRISTIN ANN | 1622 | §103 | Non-Final OA | 9d | Pending | Nov 16, 2023 |
| 18266103 | Eyedrops for Treating Scleral Thinning and Screening Method for Therapeutic Agent of Scleral Thinning | RZECZYCKI, PHILLIP MATTHEW | 1625 | Other | Non-Final OA | 9d | Pending | Jun 08, 2023 |
| 18266102 | Eyedrops for Inhibiting Myopia Progression in Children and Screening Method for Inhibitor of Myopia Progression in Children | BELL, SARA ELIZABETH | 1625 | Other | Non-Final OA | 30d overdue | Pending | Jun 08, 2023 |
| 18026232 | DEVICE AND METHOD FOR INHIBITING CHOROIDAL THINNING | EISEMAN, LYNSEY C | 3796 | §103 | Final Rejection | 42d overdue | Pending | Mar 14, 2023 |
| 16982152 | NON-INVASIVE CORNEA AND SCLERA STRENGTHENING DEVICE AND METHOD | ALLEN, ROBERT F | 3783 | §103 | Final Rejection | 35d overdue | Pending | Sep 18, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial